Refine by
Diabetes Monitoring Articles & Analysis
12 news found
“Patients with chronic kidney disease are faced with an increased risk of cardiovascular events,” said Professor Peter Rossing, Head of Complications Research at the Steno Diabetes Center Copenhagen. “As chronic kidney disease progresses silently, with oftentimes no symptoms in the early stages, patients with type 2 diabetes should be regularly ...
ByBayer AG
Key Research Survey Findings: 52 percent of healthcare providers agreed motivation is a major barrier to patients adhering to blood glucose monitoring compared to only 10 percent of people with diabetes who agreed motivation is a major barrier. ...
ByLifeScan
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced three abstracts, including two oral presentations and one poster, detailing data on type 1 diabetes (T1D) and its Phase 1/2 trial of VX-880, a stem cell-derived, fully differentiated pancreatic islet cell replacement therapy, have been accepted for presentation during the American Diabetes ...
Prior to that, while at Abbott he led one of the most successful medical device launches in history with the introduction of the FreeStyle Libre Diabetes Continuous Glucose Monitor system. At the start of his career, Mr. ...
“As most patients have no symptoms in the early stages, people with type 2 diabetes should regularly be monitored by their doctor for the earliest signs of kidney disease. ...
ByBayer AG
The peer-reviewed research appears in BMJ Open Diabetes Research & Care, a journal published in partnership with the American Diabetes Association. ...
Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in people with Type 1 diabetes and other types of insulin-dependent diabetes, presented new findings today at the 55th Annual Meeting of the European Association for the Study of Diabetes on September 16-20, 2019 in Barcelona. ...
Nearly 30,000 people across the country with Type 1 diabetes have received life-changing diabetes monitors through the NHS Long Term Plan. The innovative device, which is the size of a £2 coin and worn on the arm, means people with Type 1 do not have to carry out multiple painful finger-prick checks to monitor their blood ...
This year's cohort includes a diverse pool of companies that focus on every topic from diabetes monitoring to substance use treatment and workflow tools to senior ride sharing. ...
The Epinex G1A test for glycated albumin will be used for diabetes monitoring, screening, and diagnostics. It addresses the gap between daily blood sugar testing and HbA1c testing. ...
The function of this app is to provide educational information and awareness about diabetes. With over half a billion people around the world suffering from diabetes and millions more at risk, digital health platforms such as Am I Diabetic have the potential to provide unprecedented access to diabetes education. ...
It could offer patients a better diabetes management tool that directly measures damage (glycation) on a monthly basis. ...